Epigenetic plasticity safeguards heterochromatin configuration in mammals
Nucleic Acids Research · 07.07.2023 · 51 (12) · 6190-6207
DOI: 10.1093/nar/gkad387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 13.05.2023. Verfasst von Kei Fukuda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako351-0198, Japan. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Heterochromatin. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: RIKEN internal research fund, Japan Society for the Promotion of Science, Scientific Research on Innovative Areas.
Abstract (Originalsprache)
Heterochromatin is a key architectural feature of eukaryotic chromosomes critical for cell type-specific gene expression and genome stability. In the mammalian nucleus, heterochromatin segregates from transcriptionally active genomic regions and exists in large, condensed, and inactive nuclear compartments. However, the mechanisms underlying the spatial organization of heterochromatin need to be better understood. Histone H3 lysine 9 trimethylation (H3K9me3) and lysine 27 trimethylation (H3K27me3) are two major epigenetic modifications that enrich constitutive and facultative heterochromatin, respectively. Mammals have at least five H3K9 methyltransferases (SUV39H1, SUV39H2, SETDB1, G9a and GLP) and two H3K27 methyltransferases (EZH1 and EZH2). In this study, we addressed the role of H3K9 and H3K27 methylation in heterochromatin organization using a combination of mutant cells for five H3K9 methyltransferases and an EZH1/2 dual inhibitor, DS3201. We showed that H3K27me3, which is normally segregated from H3K9me3, was redistributed to regions targeted by H3K9me3 after the loss of H3K9 methylation and that the loss of both H3K9 and H3K27 methylation resulted in impaired condensation and spatial organization of heterochromatin. Our data demonstrate that the H3K27me3 pathway safeguards heterochromatin organization after the loss of H3K9 methylation in mammalian cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako351-0198, Japan.
- School of Biosciences, The University of Melbourne, Royal Parade, 3010 Parkville, Australia.
- World Research Hub Initiative, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.
- Cell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.
- Chromosome Dynamics Laboratory, RIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.
- Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Wako 351-0198, Japan.
ORCID-Profile: Hiroshi Kimura, Yoichi Shinkai
Förderung
- RIKEN internal research fund
- Japan Society for the Promotion of Science
- Scientific Research on Innovative Areas
- JSPS
- Japan Science and Technology
Zitieren
APA
Fukuda, K., Shimi, T., Shimura, C., Ono, T., Suzuki, T., Onoue, K., Okayama, S., Miura, H., Hiratani, I., Ikeda, K., Okada, Y., Dohmae, N., Yonemura, S., Inoue, A., Kimura, H., & Shinkai, Y. (2023). Epigenetic plasticity safeguards heterochromatin configuration in mammals. Nucleic Acids Research, 51(12), 6190-6207. https://doi.org/10.1093/nar/gkad387
Vancouver
Fukuda K, Shimi T, Shimura C, Ono T, Suzuki T, Onoue K, et al. Epigenetic plasticity safeguards heterochromatin configuration in mammals. Nucleic Acids Research. 2023;51(12):6190-6207. doi:10.1093/nar/gkad387
BibTeX
@article{Fukuda2023,
author = {Fukuda, Kei and Shimi, Takeshi and Shimura, Chikako and Ono, Takao and Suzuki, Takehiro and Onoue, Kenta and Okayama, Satoko and Miura, Hisashi and Hiratani, Ichiro and Ikeda, Kazuho and Okada, Yasushi and Dohmae, Naoshi and Yonemura, Shigenobu and Inoue, Azusa and Kimura, Hiroshi and Shinkai, Yoichi},
title = {Epigenetic plasticity safeguards heterochromatin configuration in mammals},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {12},
pages = {6190--6207},
doi = {10.1093/nar/gkad387}
}
EUVIMED